Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb®—Basics, Indications and Perspectives—A Scoping Review

T Koehler, E Schwier, J Praxenthaler… - International Journal of …, 2021 - mdpi.com
The “normal” immune response to an insult triggers a highly regulated response determined
by the interaction of various immunocompetent cells with pro-and anti-inflammatory …

Adjunctive hemoadsorption therapy with CytoSorb in patients with septic/vasoplegic shock: a best practice consensus statement

S Mitzner, K Kogelmann, C Ince, Z Molnár… - Journal of clinical …, 2023 - mdpi.com
A dysregulated host response is a common feature in critically ill patients due to both
infectious and non-infectious origins that can lead to life-threatening organ dysfunction …

Clinical utility of extracorporeal cytokine hemoadsorption therapy: a literature review

A Bonavia, A Groff, K Karamchandani, K Singbartl - Blood purification, 2018 - karger.com
Cytokines play a critical role in coordinating and amplifying a host immune response to
infection. The normal pattern of localized and systemic release of proinflammatory and anti …

Hemoperfusion in the intensive care unit

Z Ricci, S Romagnoli, T Reis, R Bellomo… - Intensive care medicine, 2022 - Springer
Multiple organ failure following a septic event derives from immune dysregulation. Many of
the mediators of this process are humoral factors (cytokines), which could theoretically be …

[HTML][HTML] Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb®) in patients …

R Paul, P Sathe, S Kumar, S Prasad… - World Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND Sepsis is a severe clinical syndrome related to the host response to
infection. The severity of infections is due to an activation cascade that will lead to an auto …

Hemoadsorption by extracorporeal cytokine adsorption therapy (CytoSorb®) in the management of septic shock: A retrospective observational study

YP Singh, SC Chhabra, K Lashkari… - … Journal of Artificial …, 2020 - journals.sagepub.com
Introduction: Sepsis results in immunologic disturbances with the release of various
inflammatory mediators such as cytokines. Cytokines can damage the cells, and the …

CytoSorb, a novel therapeutic approach for patients with septic shock: a case report

B Hinz, O Jauch, T Noky, S Friesecke, P Abel, R Kaiser - 2015 - journals.sagepub.com
Introduction Hemoadsorption using CytoSorb has gained attention as a potential
immunotherapy to control systemic inflammation and sepsis. We report on a patient with …

Continuous hemoadsorption with a cytokine adsorber during sepsis–a review of the literature

KS Houschyar, MN Pyles, S Rein… - … journal of artificial …, 2017 - journals.sagepub.com
Sepsis is a well-recognized healthcare issue worldwide, ultimately resulting in significant
mortality, morbidity and resource utilization during and after critical illness. In its most severe …

[HTML][HTML] Experience with hemoadsorption (CytoSorb®) in the management of septic shock patients

Y Mehta, C Mehta, A Kumar, JV George… - World Journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Cytokines and inflammatory mediators are the hallmarks of sepsis.
Extracorporeal cytokine hemoadsorption devices are the newer clinical support system to …

Cytokine removal in human septic shock: Where are we and where are we going?

PM Honore, E Hoste, Z Molnár, R Jacobs… - Annals of intensive …, 2019 - Springer
Although improving, the mortality from septic shock still remains high despite increased
international awareness. As a consequence, much effort has focused on alternative …